Table 3.
Proportional distribution (percent) of studies by disease and country (N = 104)
| Total | United States |
Australia | Canada | United Kingdom |
Italy | Otherb | |
| (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | |
| (104) 100 | (53) 51 | (15) 14 | (12) 12 | (6) 6 | (4) 4 | (14) 13 | |
| Asthma [8,9,17-32] | (18) 17 | (12) 12 | (2) 2 | - | - | - | (4) 4 |
| Type 1 diabetes [33-43] | (12) 12 | (6) 6 | - | - | (1) 1 | (1) 1 | (4) 4 |
| Special needs [44-55] | (11) 11 | (7) 7 | (1) 1 | - | (1) 1 | (1) 1 | (1) 1 |
| Psychiatric disorder [56-67] | (10) 10 | (4) 4 | (1) 1 | (2) 2 | 1 | - | - |
| Various diseases [68-74] | (7) 7 | (5) 5 | (1) 1 | - | - | - | (1) 1 |
| Cancer [75-79] | (5) 5 | (2) 2 | (3) 3 | - | - | - | - |
| Cardiac disorder [80-84] | (4) 4 | - | - | (1) 1 | (3) 3 | - | - |
| Sudden infant death syndrome risk [85-88] | (4) 4 | (3) 3 | - | - | - | - | (1) 1 |
| Burns [89-91] | (3) 3 | - | (2) 2 | - | - | - | (1) 1 |
| Complex health care needs post-discharge [92-94] | (3) 3 | - | - | (3) 3 | - | - | - |
| Speech-language pathology [95-97] | (3) 3 | (1) 1 | (1) 1 | (1) 1 | - | - | - |
| Chronic kidney disease (dialysis) [98,99] | (2) 2 | - | - | - | - | (2) 2 | - |
| Cystic fibrosis [100,101] | (2) 2 | (1) 1 | (1) 1 | - | - | - | - |
| Epilepsy [102,103] | (2) 2 | (2) 2 | - | - | - | - | - |
| Traumatic brain injury [10,104-107] | (2) 2 | (2) 2 | - | - | - | - | - |
| Very low birth weight [108,109] | (2) 2 | (2) 2 | - | - | - | - | - |
| Othera | (14) 13 | (6) 6 | (1) 1 | (5) 5 | - | - | (2) 2 |
a Diseases that were the topic of only 1 study that met the inclusion criteria: Anorexia nervosa (Canada) [110], endocrine (Australia) [111], feeding disorders (United States) [112], gastroenterological (United States) [113], hemophilia (Canada) [114], HIV (United States) [115], hypertension (Greece) [116], medical and surgical problems (Canada) [117], recurrent pain (Canada) [118], respiratory failure (Japan) [119], rheumatological disease (United States) [7], scoliosis (Canada) [120], sickle cell anemia (United States) [121], vascular infusion (United States) [122].
b Countries from which only 1 or 2 studies met the inclusion criteria: Germany (2; SIDS, diabetes), Netherlands (2; asthma), Norway (2; burns, diabetes), France (1; diabetes), Greece (1; hypertension), Ireland (1; special needs), Israel (1; asthma), Japan (1; respiratory failure), Multiple (1; type 1 diabetes), Spain (1; various), Taiwan (1; asthma).